Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
Apply
CLIC-1901
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step